Insights on the Indian Breast Cancer Diagnostics And Therapeutics Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025
Indian breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 11.1% during the forecast period. The major factors that are driving the market include the prevalence of breast cancer, awareness programs by government and private organizations in the country. Government agencies, NGOs and charity organizations have put great emphasis on improved breast cancer awareness among masses for promotion of early detection, providing comprehensive treatment module, providing support for breast cancer management and for screening and rehabilitation. The efforts have resulted in improved survival and quality of life of Indian breast cancer patients, however the improvement more pronounced in the urban population. The Extension for Community Healthcare Outcomes (ECHO) organizes breast cancer awareness and screening programs for rural and semi-urban Indian population. This project increased the cancer literacy amongst the rural population and awareness on early diagnosis of breast cancers and more public facilities for breast cancer treatments.
To Request a Sample of our Report on Indian
Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/indian-breast-cancer-diagnostics-therapeutics-market
Indian breast cancer diagnostics and therapeutics market are
segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer
type segment market is further classified into ductal carcinoma in-situ (DCIS),
invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC),
inflammatory breast cancer and others. In diagnostics technology, the segment
market is further classified into mammography, biopsy, position emission
tomography/computed tomography, ultrasound, and others. The therapeutics
technology segment market is further segregated into chemotherapy, hormone
therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A
full Report of Indian Breast Cancer Diagnostics And Therapeutics Market is
Available @ https://www.omrglobal.com/industry-reports/indian-breast-cancer-diagnostics-therapeutics-market
Indian Breast Cancer
Diagnostics And Therapeutics Market Segmentation
By Cancer Type
·
Ductal Carcinoma In-Situ (DCIS)
·
Invasive Ductal Carcinoma (IDC)
·
Triple Negative Breast Cancer (TNBC)
·
Inflammatory Breast Cancer
·
Others (Invasive lobular carcinoma)
By Diagnostics
·
Mammography
·
Biopsy
·
PET/CET
·
Ultrasound
·
Others (MRI)
By Therapeutics
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Others (Radiation Therapy, Surgery)
Company Profiles
·
AstraZeneca PLC
·
Bayer AG
·
GlaxoSmithKline PLC
·
Johnson & Johnson Services, Inc.
·
Merck & Co., Inc.
·
Novartis International AG
·
F. Hoffmann-La Roche AG
·
Sanofi S.A.
·
Siemens Healthcare GmbH
·
Sun Pharmaceutical Industries Ltd.
·
Pfizer Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment